GYNUITY HEALTH PROJECTS INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

BEVERLY WINIKOFF

Phone

2124481230

Tax Period

2023-01-01 to 2023-12-31

GYNUITY HEALTH PROJECTS INC, founded in 2018, is a small nonprofit in the Health Care sector that reported $481K in total revenue in fiscal year 2023. Revenue fell 70% from the prior year — a significant decline worth monitoring. Expenses of $1.6M exceeded revenue, resulting in a 229% operating deficit.

Mission

GYNUITY HEALTH PROJECTS WORKS TO DEVELOP AND ADVOCATE FOR THE USE OF SCIENTIFIC, CLINICAL AND PROGRAMMATIC EVIDENCE IN REPRODUCTIVE AND MATERNAL HEALTH, ASSURING THAT EACH INDIVIDUAL BENEFITS FROM THE FRUITS OF MEDICAL SCIENCE AND TECHNOLOGY.

Program Service Accomplishments

Program 1

Expenses: $1,054,639 Revenue: $52,013

GYNUITY HEALTH PROJECTS HAS BEEN AT THE FOREFRONT OF GLOBAL RESEARCH AND ADVOCACY EFFORTS TO IMPROVE ACCESS TO HIGH-QUALITY, SIMPLE, MEDICAL ABORTION (MA) SERVICES. IN 2023, WE STUDIED A NUMBER OF...

GYNUITY HEALTH PROJECTS HAS BEEN AT THE FOREFRONT OF GLOBAL RESEARCH AND ADVOCACY EFFORTS TO IMPROVE ACCESS TO HIGH-QUALITY, SIMPLE, MEDICAL ABORTION (MA) SERVICES. IN 2023, WE STUDIED A NUMBER OF APPROACHES FOR DE-MEDICALIZED ABORTION AND SELF-CARE APPROACHES THAT PRIORITIZE A PERSON'S AUTONOMY AND REDUCES THE NUMBER OF IN-CLINIC VISITS. WE CONFIRMED THE FEASIBILITY OF TELEMEDICINE MA SERVICES IN MEXICO, UZBEKISTAN, AZERBAIJAN, AND UKRAINE. WE HAVE CONDUCTED PROMISING RESEARCH INTO EXISTING REGISTERED COMPOUNDS THAT MIGHT BE USED IN MA REGIMENS INSTEAD OF MIFEPRISTONE WITH SIMILAR SAFETY AND EFFICACY. AT GYNUITY, WE ALSO PERFORM RESEARCH ON PROMISING MATERNAL HEALTH TECHNOLOGIES AND MODELS OF CARE THAT HAVE THE POWER TO IMPROVE HEALTH OUTCOMES. WE COMPLETED A LARGE BODY OF RESEARCH THAT ASSESSED THE USE OF LOW-DOSE ORAL MISOPROSTOL FOR LABOR INDUCTION IN WOMEN UNDERGOING TREATMENT FOR PREGNANCY-RELATED HYPERTENSIVE DISORDERS AT LARGE GOVERNMENT HOSPITALS IN NAGPUR, INDIA. WE INITIATED WORK WITH PARTNERS IN UGANDA TO CREATE NEW SELF-CARE MONITORING APP FOR DELIVERING MOTHERS AND THEIR BIRTH COMPANIONS TO HELP WITH THEIR MONITORING OF OBSTETRIC COMPLICATIONS. IN 2023, WE PUBLISHED SEVERAL NEW JOURNAL ARTICLES THAT SUMMARIZE THE RESULTS FROM THIS WORK AND WE CONTINUE TO ENGAGE STRATEGICALLY WITH PARTNERS AND LEADING HEALTH AUTHORITIES TO SHARE EVIDENCE FOR UPDATING GUIDELINES AND PRACTICES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $411,062

Program Service Revenue $52,013

Investment Income $14,597

Other Revenue $3,321

TOTAL REVENUE $480,993

Expense Breakdown

Grants Paid $0

Salaries & Benefits $954,913

Fundraising Expenses $68,554

Program Expenses $1,054,639

Other Expenses $627,326

TOTAL EXPENSES $1,582,239

Year-over-Year Comparison

	2023	2022	Change
Revenue	$480,993	$1,588,944	-0.7%
Expenses	$1,582,239	$2,171,423	-0.3%
Net Income	$-1,101,246	$-582,479	+0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$421,983

Total Directors

$204,898

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BEVERLY WINIKOFF	PRESIDENT	35.00	Officer Director	$203,538	$1,360	$204,898
GEORGE BROWN	CHAIR	0.50	Officer Director	$0	$0	$0
PAMELA BARNES	DIRECTOR	0.50	Director	$0	$0	$0
ANJU MALHOTRA	DIRECTOR	0.50	Director	$0	$0	$0
ANN SCHUTT-AINE	DIRECTOR	0.50	Director	$0	$0	$0
SILVINA RAMOS	DIRECTOR	0.50	Director	$0	$0	$0
YELENA ELYUKIN	TREASURER/ SR. DIR. OF FINANCE AND ADMINISTRATION	35.00	Officer	$118,564	$10,209	$128,773
JILL DUROCHER	INTERIM SECRETARY/SENIOR DIRECTOR	28.00	Officer	$81,697	$6,615	$88,312
ELIZABETH RAYMOND	SENIOR MEDICAL ASSOCIATE	28.00	Highest	$165,089	$1,267	$166,356

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$480,993	$1,582,239	$620,039	$-1,101,246
2022	$1,588,944	$2,171,423	$1,411,376	$-582,479
2021	$2,031,608	$2,380,300	$2,164,491	$-348,692
2020	$2,435,903	$1,933,679	$2,529,825	$502,224
2019	$1,843,476	$131,941	$1,908,486	$1,711,535